In today's ever-changing market, staying informed about OTC stocks that have the potential to surge with news can be a valuable strategy for investors seeking opportunities. Here are four companies on the OTC market that have recently made noteworthy announcements:
EPAZZ INC. (OTC: EPAZ)
EPAZ has emerged as a leading player in the field of mission-critical technologies, offering innovative solutions in drone technology, blockchain mobile apps, and cloud-based business software. Leveraging their expertise in these areas, Epazz has recently unveiled a groundbreaking development that has the potential to revolutionize battery technologies, capturing the attention of retail investors.
In a recent announcement, Epazz Inc. introduced a strategic move that aims to transform the battery technology landscape. The company has formed Galaxy Batteries Inc. as a dedicated subsidiary to house its intellectual properties for battery technology. This move signifies Epazz's commitment to pushing the boundaries of high-powered battery solutions for specialized devices and aircraft.
Epazz Inc. has been actively working on unique battery technologies designed for high-powered applications. The company is currently in the process of filing patents for its innovative battery technology, which it believes holds immense potential for future growth. By establishing Galaxy Batteries Inc., Epazz is laying the groundwork for the subsidiary to evolve into an independent company, further expanding its reach in the battery technology market.
CEO Shaun Passley, Ph.D., expressed enthusiasm for the ongoing development, stating, "When we embarked on the drone project back in 2019, we couldn't have foreseen the diverse technologies we would need to create to meet our requirements. As the project has evolved, new opportunities have arisen. We are now evaluating how best to monetize the varied technologies we have developed and provide maximum value to our company."
The recent launch of galaxybatteries.com serves as a platform for Epazz's battery technology subsidiary. This website will showcase the cutting-edge advancements made by Galaxy Batteries Inc. and provide a gateway for investors and industry professionals to explore the potential of these transformative battery technologies.
Investors are advised to closely monitor the progress of Epazz Inc. and its subsidiary, Galaxy Batteries Inc., as they continue to push the boundaries of battery technology. The innovative solutions developed by Epazz have the potential to reshape the industry and provide significant opportunities for growth in the mission-critical technology sector.
THERAPEUTIC SOLUTIONS INTERNATIONAL (OTC:TSOI)
TSOI specializes in immune modulation for treating specific diseases.
In a press release from earlier this week, TSOI announced the launch of its subsidiary, CTE Biologics, Inc. This spin-off subsidiary will become the dedicated subsidiary responsible for advancing the JadiCell adult stem cell platform for the treatment of CTE.
CTE is a condition that results from repetitive concussive or sub-concussive hits to the head, commonly observed in football players and military veterans. It is characterized by symptoms such as memory loss, impulsive behavior, impaired judgment, aggression, depression, and dementia.
Therapeutic Solutions International licensed the JadiCell platform for CTE treatment in 2019 and obtained IND number 27377 in April 2021. The company is currently addressing FDA inquiries to prepare for formal clinical trials. Furthermore, they have provided JadiCells under the Right to Try Law to multiple patients suffering from CTE.
Dr. James Veltmeyer, Chief Medical Officer of Therapeutic Solutions International, highlighted the significance of the FDA's agreement with their definition of CTE in living patients. He expressed confidence in obtaining clearance to initiate formal trials based on the demonstrated safety of JadiCells in a peer-reviewed publication following their interaction with the FDA.
Timothy Dixon, President and CEO of Therapeutic Solutions International, noted that their approach to CTE has the potential to address a condition that is currently challenging to diagnose in living patients. The creation of CTE Biologics allows for specialization and focus while leveraging existing resources within Therapeutic Solutions International.
These advancements could have significant implications for the company's future endeavors and potential growth in the medical field.
GLOBAL ROUNDTABLE CORPORATION INC. (OTC: GRCU)
GRCU, formerly Green Cures & Botanical Distribution Inc., operates as a holding company in the health and wellness segment, providing products and ancillary services in mental wellness and Optical-Vision medical care.
In a recent press release, GRCU announced a significant change. The company has rebranded itself as Global Roundtable Corporation, reflecting its commitment to customers, shareholders, and the community.
CEO Robert Tanko expressed pride in the name change, stating, "Our new company image signifies our dedication to delivering real value to shareholders." As a gesture of goodwill, some shareholders retired common stock shares, which will be replaced with preferred shares. Global Roundtable Corporation intends to utilize preferred shares for future acquisitions and has no plans for a reverse split.
The company also reported strong sales numbers for its subsidiary, Marvel Visions. Gross sales in 2022 amounted to approximately $452,000, with a substantial portion coming from high-end glasses. First-quarter financials for the current year reached $112,000, and projected second-quarter sales are expected to reach $175,000.
President Robert Keith Tanko expressed satisfaction with Marvel Visions' performance and highlighted future expansion potential.
Investors should closely monitor Global Roundtable Corporation's ongoing initiatives, including the implementation of the new name, share retirement, and strategic sales growth of Marvel Visions.
SOLAR INTEGRATED ROOFING CORP. (OTC: SIRC)
SIRC operates as an integrated solutions provider specializing in solar power, roofing, and EV charging systems for commercial and residential properties across North America. While SIRC may not be considered a leading company, it has been making significant strides in its industry.
In their latest press release, SIRC announced a notable milestone-a binding Letter of Commitment (LOC) with Tribeca Energy, represented by Global Fund LLC and Neo Energy Storage Ltd. This strategic partnership represents a substantial development for SIRC, potentially propelling its growth trajectory.
The LOC outlines the terms and conditions of SIRC's commitment to sell certain shares to Tribeca Energy in exchange for investment. Upon completion of the share exchange agreement, Tribeca Energy will secure 100% ownership of SIRC's shares and the majority of its board seats.
According to the agreement, Tribeca Energy intends to consummate a merger agreement and list on either the NYSE or Nasdaq by October 30, 2023, subject to the completion of necessary documents within 12 months from the LOC's date.
Brad Rinehart, CEO of SIRC, expressed his enthusiasm about the definitive agreement, stating, "Our objective is to establish ourselves as a premier all-inclusive alternative energy solution in the market, and this partnership represents another significant step towards achieving that goal. We anticipate that this collaboration will have a positive impact on SIRC's bottom line, benefiting our shareholders and constituents alike."
Their overarching objective is to contribute to the decarbonization of the world's electricity grid systems by 2050 and foster a sustainable future through energy security.
The potential merger with Tribeca Energy positions SIRC to consolidate its already extensive solar proposition outreach and integrate long duration energy storage capabilities. This alliance has the potential to significantly enhance SIRC's market presence and create ample growth opportunities in the alternative energy sector.
The successful completion of this agreement could serve as a major catalyst for SIRC's future prospects.
Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Epazz Inc. to assist in the production and distribution of content. 'CGR' is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content.
CONTACT: CapitalGainsReport
Mark McKelvie
Editor
Markrmckelvie@gmail.com
585-301-7700
.
EPAZZ, INC. 
